The Tesamorelin & Ipamorelin Stack: A Growth Hormone Secretagogue Research Guide
Tesamorelin and Ipamorelin — two of the most researched growth hormone secretagogues. How they work together, what the research shows, and why combo protocols dominate the literature. USA manufactured, >99% purity. For Research Use Only.
Jun 30, 2026 | 14 min read
What Are Tesamorelin and Ipamorelin?
Tesamorelin and Ipamorelin are two distinct research compounds that work on the growth hormone axis through completely different mechanisms – making their combination one of the most studied growth hormone-related research protocols available.
TESAMORELIN is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) – the peptide your hypothalamus naturally produces to signal the pituitary gland to release growth hormone. Tesamorelin is a 44 amino acid synthetic GHRH analog that binds to GHRH receptors in the anterior pituitary, stimulating the natural, pulsatile release of growth hormone. It is the only GHRH analog with an FDA approval – approved for HIV-associated lipodystrophy – making it one of the most clinically validated compounds in the GH secretagogue research space.
IPAMORELIN is a selective growth hormone secretagogue – a compound that mimics ghrelin (the hunger hormone) to trigger growth hormone release from the pituitary through a completely independent receptor pathway. Ipamorelin is notable in research for its selectivity: it stimulates GH release without significantly increasing cortisol, prolactin, or other hormones that older GHRPs (Growth Hormone Releasing Peptides) were known to elevate. This selectivity makes it a cleaner research tool for studying GH-related biological effects.
